MAPT and Alzheimer disease: AD is characterized by cognitive dysfunction, accumulation of amyloid-beta (Aβ) plaques in the cerebral cortex, and hyperphosphorylated tau protein-mediated neuronal damage that is initiated in the hippocampus and cortex region of the brain [93].